Decreasing angiogenesis vasa vasorum through Lp-PLA2and H2O2inhibition by PSP from Ganoderma lucidum in atherosclerosis: In vivo diabetes mellitus type 2

Closed

Titin Andri Wihastuti, Reyhan Amiruddin, Fibe Yulinda Cesa, Amalia Istiqamah Alkaf, Meddy Setiawan, Teuku Heriansyah

2019 Journal of Basic and Clinical Physiology and Pharmacology Vol. 30 Issue 6 Article Cited by 15 SDG 3SDG 17 Quartile

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a major risk factor of atherosclerosis. Hyperglycemia in T2DM causes advanced formation of glycation end products (AGE) which leads to oxidative stress and chronic inflammation. Oxidative stress occurs due to increased levels of reactive oxygen species (ROS) such as H2O2. On the other hand, lipoprotein-associated phospholipase (Lp-PLA2) has pro-inflammatory effects, which cause instability of atherosclerosis plaques. This condition causes hypoxemic cells to stimulate HIFα induced vasa vasorum angiogenesis. This study aims to understand the potential of PSP as an anti-angiogenic agent through decreased levels of H2O2 and Lp-PLA2 leading to the decline of vasa vasorum angiogenesis in diabetic rat model. In addition, this study also measured the lipid profile of diabetic rat model in relation to vasa vasorum angiogenesis. Methods: True laboratory experiment with randomized post-test control of group design using 25 wistar rats (Rattus norvegicus) were divided into five groups; one normal group and four group with High Fat Diet (HFD) and low dose streptozotocin (30 mg/kgBW) injection sc, treated with placebo and three various doses of PSP 50, 150, 300 mg/kgBW. Results: ANOVA test (p < 0.05) shows that there is a significant influence of polysaccharide peptide (PSP) feeding on the decreased amount of vasa vasorum angiogenesis (p = 0.00), lipid profile (cholesterol total and triglyceride; p = 0.01, p = 0.001), and amount of H202 (p = 0.003). The amount of Lp-PLA2 declined to (p = 0.184). This result indicates that PSP prevents inflammation in atherosclerosis. Conclusions: PSP of Ganoderma lucidum is an anti-angiogenic agent in T2DM. © 2019 Walter de Gruyter GmbH, Berlin/Boston.

Affiliations

Brawijaya University, Department of Biomedical Nursing, Faculty of Medicine, Malang, Indonesia; Master Program of Biomedical, Faculty of Medicine, Brawijaya University, Malang, Indonesia; Bachelor Programme, Faculty of Medicine, Brawijaya University, Malang, Indonesia; Department of Internal Medicine, Faculty of Medicine, University of Muhammadiyah, Malang, Indonesia; Department of Cardiology, Faculty of Medicine, Syiah Kuala University, Aceh, Indonesia

Research at a Glance

Premium content — register to unlock

Research at a Glance

Register to unlock

Topics & SDG Alignment

Premium content — register to unlock

Topics & SDG Alignment

Register to unlock

Collaboration

Premium content — register to unlock

Collaboration

Register to unlock

Author Profile (Selected)

Premium content — register to unlock

Author Profile (Selected)

Register to unlock

References Overview

Premium content — register to unlock

References Overview

Register to unlock

Journal & Source

Premium content — register to unlock

Journal & Source

Register to unlock

Metadata & Integrity

Premium content — register to unlock

Metadata & Integrity

Register to unlock